IP Library Granted Patent US 9,707,520
Granted Patent B2
US 9,707,520 · App. 15/237,052 · Granted Jul 18, 2017

Composition, system, and method for treating water systems

Inventors: Adrian Denvir (Richardson, TX); James Gregory Edford (Richland Hills, TX); Angela L Delegard (Denton, TX); Scott M Boyette (Irving, TX)
Assignee: NCH Corporation
B01D65/08A01N37/36A01N59/00B01D61/002B01D61/025B01D61/027B01D61/145B01D61/147B08B9/0856C02F1/50C02F1/68C02F1/683C11D3/2086C11D3/48B08B3/04B08B9/00C02F1/001C02F1/008C02F1/441C02F1/442C02F1/444C02F1/445C02F1/685C02F1/687C02F1/76C02F1/766C02F2101/30C02F2103/023C02F2303/02C02F2303/04C02F2303/08C02F2303/20C02F2303/22C02F2305/04C02F2305/14C02F2307/08C11D1/38C11D3/33
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,707,520
App. No.
15/237,052
Granted
Jul 18, 2017
Kind
B2
Abstract

A composition for treating a water system or membrane fluid system, such as a reverse osmosis system, to remove scale, microorganisms and biofilm, and corrosion by-products. The composition comprises chelating agents and a surfactant. The composition may be a solid dissolved by water or solvent in the system being treated or may be a pre-mixed foam or aerosol. A method for using such a treatment composition comprises contacting the treatment composition with substantially all parts of the water system and draining the treatment composition from the system before resuming normal operations. For certain systems, the method also comprises draining some existing water in the water system to remove prior treatment compositions and filling or rinsing the system with fresh water prior to adding the treatment composition.

Claims (23)

1. A method of removing biofilm and treating a fluid system containing a membrane, the method comprising the steps of:

adding a surfactant, a first chelating agent, and a second chelating agent or other ingredient that will react with the first chelating agent to produce a second chelating agent to the fluid system in amounts sufficient to provide concentrations of at least 0.00015 M for the surfactant, about 0.001M to 0.01M for the first chelating agent, and about 0.0005 M to 0.005M for the second chelating agent when mixed with a volume of fluid in the fluid system containing the membrane or portion thereof being treated;

removing biofilm by circulating the fluid containing the surfactant and chelating agents through at least a portion of the fluid system to contact the membrane;

wherein the membrane is a nanofiltration, ultrafiltration, microfiltration, forward osmosis, reverse osmosis, or particle filtration membrane;

wherein the fluid system is a water system and the fluid comprises water; and

wherein the first chelating agent is citric acid, the second chelating agent is sodium citrate, and the other ingredient is sodium bicarbonate.

2. The method of claim 1 further comprising the steps of:

adding a corrosion inhibitor and a biocide to the fluid in the fluid system; and

circulating the fluid containing the corrosion inhibitor and the biocide through at least a portion of the fluid system.

3. The method according to claim 1 wherein the surfactant is an ammonium bromide compound, an ammonium chloride compound, or a sodium sulfonate compound.

4. The method of claim 1 wherein the fluid system is a reverse osmosis system comprising the membrane, a feed line for feeding the fluid to the membrane, a concentrate line exiting the membrane and a permeate line exiting the membrane, the method further comprising the step of:

flowing the fluid containing the surfactant and chelating agents from the feed line to the concentrate line to contact the membrane.

5. The method of claim 2 wherein the corrosion inhibitor is added and circulated for a period of time prior to adding the surfactant.

6. The method of claim 2 wherein the surfactant is added and circulated for a period of time prior to adding the first chelating agent.

7. The method of claim 2 wherein the surfactant and chelating agents circulate for a period of time prior to adding the biocide.

8. The method of claim 2 wherein the surfactant, the first chelating agent, the second chelating agent or other ingredient that will react with the first chelating agent to produce a second chelating agent, and biocide are added at the same time.

9. The method of claim 4 further comprising the step of removing substantially all of the fluid containing the surfactant and chelating agents from the reverse osmosis system after the circulating step; and

rinsing the reverse osmosis system.

10. The method according to claim 4 wherein the surfactant is in a range of about 0.00015 M to 0.0015 M when mixed with the volume of fluid in the reverse osmosis system being treated.

11. The method of claim 4 further comprising the step of filtering the fluid as it circulates through the reverse osmosis system to remove dislodged biofilm material.

12. The method according to claim 4 wherein the surfactant, the first chelating agent, and the second chelating agent or other ingredient that will react with the first chelating agent to produce a second chelating agent are in solid form prior to being added to the fluid of the reverse osmosis system being treated.

13. The method of claim 4 wherein the adding step comprises diverting at least some fluid from the concentrate line to a treatment system comprising a feeder containing the surfactant and chelating agents in dry or powdered form and adding the surfactant and chelating agents to the diverted fluid.

14. The method of claim 13 wherein the circulating step further comprises returning the diverted fluid with the surfactant and chelating agents to the feed line to flow from the feed line to the concentrate line to contact the membrane.

Assignments (7)
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; DIVERSEY, INC.; DIVERSEY TASKI, INC.; INNOVATIVE WATER CARE, LLC; NCH CORPORATION; NCH LIFE SCIENCES LLC; SOLENIS TECHNOLOGIES, L.P.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073570/0838 →
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; NCH CORPORATION; NCH LIFE SCIENCES LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073570/0763 →
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; NCH CORPORATION; NCH LIFE SCIENCES LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073570/0920 →
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; NCH CORPORATION; NCH LIFE SCIENCES LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 073570/0750 →
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; DIVERSEY, INC.; INNOVATIVE WATER CARE, LLC; NCH CORPORATION; NCH LIFE SCIENCES LLC; SOLENIS TECHNOLOGIES, L.P.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 073564/0584 →
SECURITY INTEREST Recorded Nov 14, 2025
From: CHEM-AQUA, INC.; DIVERSEY, INC.; INNOVATIVE WATER CARE, LLC; NCH CORPORATION; NCH LIFE SCIENCES LLC; SOLENIS TECHNOLOGIES, L.P.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 073564/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2016
From: DENVIR, ADRIAN; EDFORD, JAMES GREGORY; DELEGARD, ANGELA L.; BOYETTE, SCOTT M.
To: NCH CORPORATION
Reel/Frame 039721/0665 →
Continuity (3)
Continuation In Part 13745211 · Jan 18, 2013
Provisional Application 61587966 · Jan 18, 2012
Related Publication 20160354727A1 · Dec 8, 2016